Evonik Industries announced that its plans are fully on schedule to build a second world-scale plant in Singapore for the production of the amino acid DL-methionine.
The company marked the official start of construction with a symbolic groundbreaking ceremony Oct. 19 that was officiated by Tharman Shanmugaratnam, Singapore deputy prime minister and coordinating minister for economic and social policies.
The complex will have an annual production capacity of 150,000 metric tons and is expected to become operational in 2019, with investment costs of more than 500 million euros. Evonik sells DL-methionine under the brand name MetAMINO.
“Our methionine complex, which came on stream in late 2014 on Jurong Island, is a success story. This led to our decision to build a second plant next to it,” said Klaus Engel, chairman of the executive board of Evonik Industries. “The demand for MetAMINO for animal nutrition is continuing to grow at a very fast rate in Asia."
The new plant will produce not only methionine but also all strategically important precursors to guarantee product quality and supply security, the company said.
The new production complex will increase Evonik’s annual capacity of DL-methionine to a total of approximately 300,000 mt in Asia and to approximately 730,000 mt worldwide. The specialty chemicals company produces the amino acid in its world-scale plants in Antwerp, Belgium; Wesseling/Cologne, Germany; Mobile, Ala., and Singapore.
DL-methionine is an essential amino acid that must be absorbed through feed intake. As a feed additive, it contributes to the efficient, healthy and environmentally friendly nutrition of livestock, particularly poultry and swine. That makes it an important component of ensuring a sustainable animal protein supply for the world’s growing population.